| Name | Title | Contact Details |
|---|
Retreat Capital Management is a Lake Forest, CA-based company in the Business Services sector.
Mammoth Water and Fire Restoration is a Pleasant Gap, PA-based company in the Business Services sector.
Nooks is tackling the challenging necessity of Classified-Infrastructure-as-a-Service (CIaaS) for both industry and government customers to accelerate collaboration, technology adoption and engagement between industry and government to win the Great Power competition. Nooks will lower the barrier-of-entry/scale to qualified companies to engage in classified environments to rapidly bring innovative solutions to reality and revolutionize the landscape of classified operations. We strive to build a culture of "People First, Service Always." We are a Veteran Owned Small Business, and we believe that service to country can continue even after leaving the military/government. We want each of our employees to grow, learn, and achieve more than they ever thought possible in a culture that embraces diverse backgrounds and perspectives. Come join our team!
Cenergy is a East Aurora, NY-based company in the Business Services sector.
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.